High-throughput screening (HTS) is an automated drug discovery technique for identification of active compounds against a compound library. Use HTS readers and integrated assay preparation / analysis workstations to screen your compounds. Identify active compounds against various HTS libraries, including membranes, proteins and peptides and HTS cell lines. Find the best high-throughput screening products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.
Human KCa2.3 potassium ion channel-expressing, division-arrested cells (CHO-K1). Cat#: CT4182. Cryopreserved irradiated cells, 6 million cells per vial.. Platform validation: FlexStation III
Human TRPA1 ion channel-expressing, division-arrested cells. (CHO). Cat#: CT4191. Cryopreserved irradiated cells, 3 vials: 2x10E6 cells/vial. Platform validation: FlexStation III
Human TRPM8 ion channel-expressing, division-arrested cells. (CHO). Cat#: CT4193. Cryopreserved irradiated cells, 3 vials: 2x10E6 cells/vial. Platform validation: FlexStation III
Human ClC-1 chloride ion channel-expressing, division-arrested cells (CHO-K1). Cat#: CT4175. Cryopreserved irradiated cells, 6 million cells per vial. Platform validation: PatchXpress®
Human HCN2 ion channel-expressing, division-arrested cells (CHO-K1). Cat#: CT4115. Cryopreserved irradiated cells, 6 million cells per vial. Platform validation: PatchXpress®
Human TRPC6 ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7192. Cryopreserved cells, 6x10E6 cells/vial. Platform validation:
Human Kv11.1 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7001. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT, IonWorks® Quattro
Human HCN4 hyperpolarization-gated ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7006. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT
Human Kir3.1/Kir3.4 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7017. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®
Human Kv7.3/Kv7.5 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7018. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, FLIPR®
Human α4/β2 Nicotinic Acetylcholine Receptor-expressing, transiently transfected cells (HEK293). Cat#: CT7023. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: QPatch™ HT
Human TRPM5 ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7031. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: FLIPR®
Human TRPM7 ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7032. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: FLIPR®
Human TRPP1/TRPP2 ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7033. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: FLIPR®
Human TRPV2 ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7034. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: FLIPR®
Human Kir1.1 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7102. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT
Human Kir2.1 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7103. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT
Human Kir3.1/Kir3.2 potassium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7104. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT, IonWorks® Quattro, FLIPR®
Human TRPV1 ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7105. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, FLIPR®
Human Cav3.2 calcium ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7106. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT, FLIPR®
Human HCN1 hyperpolarization-gated ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7114. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT
Human HCN3 hyperpolarization-gated ion channel-expressing, transiently transfected cells (HEK293). Cat#: CT7116. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, QPatch™ HT
Human 5-HT3A Serotonin Receptor-expressing, transiently transfected cells (HEK293). Cat#: CT7117. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, FLIPR®
Human NMDA (NR1/NR2A) Receptor-expressing, transiently transfected cells (HEK293). Cat#: CT7120. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: FLIPR®
Human NMDA (NR1/NR2B) Receptor-expressing, transiently transfected cells (HEK293). Cat#: CT7121. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: FLIPR®
